Sickle cell disease: open trials in Greece

• NCT06975865

  The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  Trial Treatment · Phase 3 · Sanofi

  Athens · Athens · Pátrai

  Registry updated 2026-10-15

• NCT06699849

  Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  Trial Treatment · Phase 2 · CSL Behring

  Laiko General Hospital of Athens, Athens

  Registry updated 2026-10-08

• NCT06609226

  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Hippokration Hospital, Athens · General Hospital Of Larissa Koutlibaneio And Triantafylleio, Larissa · General University Hospital Of Patras, Patras · Ippokratio General Hospital of Thessaloniki, Thessaloniki

  Registry updated 2026-09-18

• NCT06612268

  A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Nosokomeio Paidon I Agia Sofia, Athens · Hippokration Hospital, Athens · Laiko General Hospital of Athens, Athens · University General Hospital of Ioannina, Ioannina · University General Hospital of Thessaloniki - AHEPA, Thessaloniki

  Registry updated 2026-09-17

• NCT05431088

  A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  Trial Treatment · Phase 2/3 · Pfizer

  Nosokomeio Paidon I Agia Sofia, Athens · Hippokration Hospital, Athens · Laiko General Hospital of Athens, Athens

  Registry updated 2026-08-18

• NCT05799118

  Study of the Role of Genetic Modifiers in Hemoglobinopathies

  Research · Cyprus Institute of Neurology and Genetics

  Laiko General Hospital, Athens · Hippokrateio Hospital of Athens, Athens · National and Kapodistrian University of Athens, Athens · General Hospital of Larissa, Larissa

  Registry updated 2024-03-20

All Sickle cell disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error